- Home
- HIT vs NTRB Comparison
HIT vs NTRB Comparison
Compare HIT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIT | NTRB |
|---|---|---|
| Founded | 1964 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.4M | 71.7M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | HIT | NTRB |
|---|---|---|
| Price | $1.38 | $4.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 624.5K | 23.1K |
| Earning Date | 11-10-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $30,723,490.00 | $2,278,321.00 |
| Revenue This Year | $70.02 | $30.17 |
| Revenue Next Year | $44.08 | $3,394.36 |
| P/E Ratio | $64.30 | ★ N/A |
| Revenue Growth | ★ 55.15 | 12.69 |
| 52 Week Low | $0.51 | $3.72 |
| 52 Week High | $7.59 | $11.78 |
Technical Indicators
Market Signals| Indicator | HIT | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 37.69 |
| Support Level | $1.03 | $4.35 |
| Resistance Level | $1.46 | $4.77 |
| Average True Range (ATR) | 0.17 | 0.42 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 61.40 | 19.04 |
Price Performance
Historical ComparisonAbout HIT Health In Tech Inc.
Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.